黑料网

Journal of Pharmacokinetics & Experimental Therapeutics
黑料网

Our Group organises 3000+ Global Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ 黑料网 Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

黑料网 Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)
  • Short Communication   
  • J Pharmacokinet Exp Ther,

Adalimumab Biosimilar Adalimumab-adbm and Reference Product Population Pharmacokinetics in Healthy Persons and Patients with Rheumatoid Arthritis to Determine Pharmacokinetic Similarities

Yanhua Ding*
Deparatment of Pharamaceutics, Phase I Clinical Research Center, The First Hospital of Jilin University, Jilin, China
*Corresponding Author : Yanhua Ding, Deparatment of Pharamaceutics, Phase I Clinical Research Center, The First Hospital of Jilin University, Jilin, China, Email: dingyanh@jlu.edu.cn

Received Date: Jun 02, 2022 / Published Date: Aug 08, 2022

Citation: Ding Y (2022) Adalimumab Biosimilar Adalimumab-adbm and Reference Product Population Pharmacokinetics in Healthy Persons and Patients with Rheumatoid Arthritis to Determine Pharmacokinetic Similarities. J Pharmacokinet Exp Ther 6: 151.

Copyright: © 2022 Ding Y. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

International Conferences 2024-25
 
Meet Inspiring Speakers and Experts at our 3000+ Global

Conferences by Country

Medical & Clinical Conferences

Conferences By Subject

Top